MedTrace Logo

NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain

NCT00258622 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2007-11-16

No results posted yet for this study

Summary

Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine and placebo in patients with peripheral chronic neuropathic pain.

Conditions

Interventions

DRUG

NS1209

DRUG

Lidocaine

Sponsors & Collaborators

  • NeuroSearch A/S

    collaborator INDUSTRY

  • Danish Pain Research Center

    lead OTHER

Principal Investigators

  • Troels S Jensen, MD, PhD · Danish Pain Research Center, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00258622 on ClinicalTrials.gov